Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells
- PMID: 8547681
Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells
Abstract
A receptor tyrosine kinase (RTK), TIE (tyrosine kinase that contains immunoglobulin-like loops and epidermal growth factor [EGF] homology domains), is expressed in vascular endothelial and hematopoietic cells. We generated monoclonal antibodies (MoAbs) against the extracellular domain of TIE and a polyclonal antibody against the TIE carboxyterminus and used them to analyze expression of TIE in hematopoietic cells. Western blotting detected two forms of TIE protein with a molecular mass of 135 and 130 kD in hematopoietic and endothelial cells. Northern blotting analysis revealed that TIE was expressed preferentially in undifferentiated cell lines, especially when megakaryocytic, but not erythroid differentiation was induced. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed that TIE was predominantly expressed in the human hematopoietic progenitor fraction, CD34+ cells. Fluorescence-activated cell sorting (FACS) showed that 42% of CD34+ and 17% of KIT-positive (KIT+) cells were TIE-positive (TIE+). The majority (81%) of the primitive hematopoietic stem cells, CD34+CD38- cells, were TIE+. Assays of progenitor cells and long-term culture-initiating cells (LTC-IC) showed that the TIE+ fraction contained more primitive cells than the TIE- fraction. Some TIE+ cells were in the CD34- fraction, which were CD19+ and CD20+ (B cells). These findings indicate that TIE has a unique spectrum of expression in primitive hematopoietic stem cells and B cells. Although its ligand has not been identified, TIE and its ligand may establish a novel regulatory pathway not only in early hematopoiesis, but also in the differentiation and/or proliferation of B cells.
Similar articles
-
The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells.Blood. 1996 Mar 15;87(6):2212-20. Blood. 1996. PMID: 8630381
-
Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.Blood. 1997 Jul 1;90(1):111-25. Blood. 1997. PMID: 9207445
-
Up-regulation of Tie gene expression by leukemia inhibitory factor and steel factor in CD34+ cells from human umbilical cord blood.J Leukoc Biol. 1997 Oct;62(4):510-6. doi: 10.1002/jlb.62.4.510. J Leukoc Biol. 1997. PMID: 9335322
-
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
-
The expression of FMS, KIT and FLT3 in hematopoietic malignancies.Leuk Lymphoma. 1994 Apr;13(3-4):223-7. doi: 10.3109/10428199409056285. Leuk Lymphoma. 1994. PMID: 7519507 Review.
Cited by
-
Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors.World J Gastroenterol. 2005 Feb 21;11(7):964-9. doi: 10.3748/wjg.v11.i7.964. World J Gastroenterol. 2005. PMID: 15742397 Free PMC article.
-
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.Cancers (Basel). 2022 May 16;14(10):2446. doi: 10.3390/cancers14102446. Cancers (Basel). 2022. PMID: 35626056 Free PMC article. Review.
-
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.J Exp Med. 2001 May 7;193(9):1005-14. doi: 10.1084/jem.193.9.1005. J Exp Med. 2001. PMID: 11342585 Free PMC article.
-
Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project.BMC Genomics. 2024 May 16;25(1):484. doi: 10.1186/s12864-024-10353-8. BMC Genomics. 2024. PMID: 38755526 Free PMC article.
-
Hematopoietic stem cells.Methods Enzymol. 2006;419:149-79. doi: 10.1016/S0076-6879(06)19007-2. Methods Enzymol. 2006. PMID: 17141055 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous